Skip to main content
PMC home page
Scientific Reports logoLink to Scientific Reports
. 2016 Dec 21;6:39540. doi: 10.1038/srep39540

High resolution crystal structure of the catalytic domain of MCR-1

Guixing Ma 1, Yifan Zhu 1, Zhicheng Yu 1, Ashfaq Ahmad 1, Hongmin Zhang 1,a
PMCID: PMC5175174  PMID: 28000749

Abstract

The newly identified mobile colistin resistant gene (mcr-1) rapidly spread among different bacterial strains and confers colistin resistance to its host, which has become a global concern. Based on sequence alignment, MCR-1 should be a phosphoethanolamine transferase, members of the YhjW/YjdB/YijP superfamily and catalyze the addition of phosphoethanolamine to lipid A, which needs to be validated experimentally. Here we report the first high-resolution crystal structure of the C-terminal catalytic domain of MCR-1 (MCR-1C) in its native state. The active pocket of native MCR-1C depicts unphosphorylated nucleophilic residue Thr285 in coordination with two Zinc ions and water molecules. A flexible adjacent active site loop (aa: Lys348-365) pose an open conformation compared to its structural homologues, suggesting of an open substrate entry channel. Taken together, this structure sets ground for further study of substrate binding and MCR-1 catalytic mechanism in development of potential therapeutic agents.

Since the clinical introduction of penicillin in the 1940s, antibiotics have remained the first choice for treatment against bacterial infections. Emergence of bacterial pathogens with acquired resistance to most of the available antimicrobial agents, namely ‘superbugs’, has greatly restricted the therapeutic choices in last decade1. It has become a challenge to treat infections caused by Gram-negative bacteria, such as Pseudomonas aeruginosa and Acinetobacter baumannii2,3. Nowadays, many of the pathogenic and common non-pathogenic bacteria harbor antibiotic resistance genes4, that is spreading and has been a global nuisance.

Infections caused by Gram negative bacteria are primarily treated by β-lactam antibiotics, such as penicillins, cephalosporins and carbapenems. However, the acquired β-lactam hydrolysing genes like metallo-β-lactamase (blaNDM-1)5 and Klebsiella pneumoniae carbapenemase (blaKPC)6 have limited the efficacy of β-lactam antibiotics5,7,8,9,10,11. Cationic polypeptides like polymyxin B and colistin (polymyxin E) are regarded as the most effective weapons to combat β-lactam resistant bacteria infections12. Structurally and pharmacologically similar polymyxin B and colistin have shown broad-spectrum activities against Gram negative bacteria. However, the rapid spread of resistant bacteria accelerate the global use of colistin in both clinical settings and animal production13, which will inevitably give rise to colistin resistant bacteria eventually12.

Recently, Liu et al. reported a plasmid-borne colistin resistant gene (mcr-1) from China14, which was quickly reaffirmed in strains isolated from Denmark15, Germany16, France17, Netherland18, Switzerland19, United States20, Belgium21, Italy22 and Vietnam23. This indicates global spreading of bacteria harboring this plasmid-borne colistin resistance. Further, in contrast to early reported chromosome-borne polymyxin resistant genes24,25,26, mcr-1 can be quickly transmitted among bacterial community through horizontal transfer. Therefore, transfer of colistin resistance to multidrug resistant Enterobacteriaceae that already harbor blaNDM-1 or blaKPC-2 is of a particular concern. Surprisingly, strains holding both resistant genes (mcr-1 and blaNDM-9, mcr-1.2 and blaKPC-3) have been rapidly identified in many recent studies16,19,21,27,28,29,30,31.

Based on sequence alignment, MCR-1 should be a phosphoethanolamine transferase, a member of YhjW/YjdB/YijP superfamily32 which catalyzes the addition of phosphoethanolamine to lipid A moiety of lipopolysaccharides (LPS) and therefore confers colistin resitance to its host33,34. MCR-1 homologues LptA and EptC can modify the 1′ and 4′ phosphoryl groups of lipid A using phosphoethanolamine (PEA) as a substrate. LptA can specifically transfer PEA to only lipid A phosphoryl groups32 while EptC shows a much broader substrate tolerance, such as 1′ and 4′ phosphoryl groups of lipid A, the first heptose residue of the inner-core oligosaccharide of lipooligosaccharide (LOS), residue Thr75 of the flagellar rod protein FlgG and the N-linked glycans of numerous glycoproteins35,36,37,38. However, the substrate preference of MCR-1 remains un-characterized to date. To understand the molecular mechanism of colistin resistance and structural features, here we report the X-ray structure of the C-terminal catalytical domain of MCR-1 (aa: 219–541, MCR-1C for short) determined at 1.45 Å resolution. Our results illustrated the detailed structure of MCR-1C which will help in the understanding of the catalysis mechanism of MCR-1 and potential drug design against colistin resistance.

Results

Overall structure of MCR-1

MCR-1 contains two domains, one N-terminal transmembrane domain and one periplasmic C-terminal catalytic domain33. Several attempts were made to express full-length MCR-1 that resulted in insoluble protein whereas two truncations (aa: S181-R541 and T219-R541) were successfully expressed and crystallized. Crystals of the longer and shorter truncations diffracted to 2.2 Å and 1.45 Å, respectively. Thus, the shorter truncation was used for structure determination whereas the longer one was considered for ICP-MS analysis. The protein was crystallized in space group P212121 having one MCR-1C molecule in the asymmetric unit with a solvent content of 42.5%. The structure was solved by single-wavelength anomalous scattering (SAD) method using the anomalous signal of zinc ions with well-defined electron density map for all the residues in the construct.

Several structural homologues from hydrolase superfamily are identified via online DALI server39 including lipooligosaccharide phosphoethanolamine transferase A from Neisseria gonorrhoeae (LptA, PDB: 4KAV and 4KAY)33, phosphoethanolamine transferase C from Campylobacter jejuni (EptC, PDB: 4TN0)34, choline sulfatase (betC, PDB: 4UG4)40 and phosphonate monoester hydrolase (PMH, PDB: 2W8S)41. The nearest structural homologues are LptA and EptC with sequence identities of 40–41% whereas betC and PMH are distant homologues having sequence identities of 16% and 13%, respectively.

The MCR-1C adopted an α/β/α topology with seven β-strands, sandwiched between two layers of α-helices (Fig. 1a). Based on structural superimposition, MCR-1C is similar to its homologues LptA and EptC (Fig. 1b,c) with a r.m.s.d of 1.58 Å and 1.56 Å (all C-alpha), respectively. We observed that the central β sheets topology is well-superimposed to LptA and EptC while loops adjacent to the active site and the C-terminal fragment are variable (Fig. 1b,c). The conformational variations of the loops adjacent to the active site may infer to the substrate specificity of these enzymes. During review of this manuscript, the other crystal structure of MCR-1 (the C-terminal domain of MCR-1 from residue D218 to residue R541, cMCR-1) was released with PDB code 5K4P42. Superposition of current structure to cMCR-1 (5K4P) gives an r.m.s.d value of only 0.49 Å for 323 C-alpha atoms, indicating that these two structures are almost identical. The most different region between these two structures is a loop located at the tip of the structure (aa: 416–422).

Figure 1. Overall structure of MCR-1C and comparison with LptA and EptC.

Figure 1

Open in a new tab

MCR-1C, LptA (PDB: 4KAY), EptC (PDB: 4TN0) are shown in cartoon representation. The labeled key residues and active site metal ions are represented in ball-and-stick and sphere, respectively. (a) Overall structure of MCR-1C. The nucleophilic residue T285 and three disulfide bridges are shown as ball-and-stick. The helix locked by a disulfide bond to the central β sheet is shown in green. (b,c) Structural superimpositions (front and back view) of MCR-1C, LptA and EptC are shown in grey. The significant variable loops are highlighted in cyan (MCR-1C), green (LptA) and orange (EptC).

MCR-1C consists of three disulfide bridges as revealed in the crystal structure (Fig. 1a, shown as ball-and-stick models). In contrast, LptA and EptC retain five and three, respectively. Moreover, only two disulfide bridges, Cys281-Cys291 and Cys414-Cys422 retain their sequence and structural conservation among all the three structures. The Cys414-Cys422 bridge stabilized a loop (aa: Lys409-Glu423) located at the top of the protein whereas Cys281-Cys291 completes the catalytic site by locking a smaller α-helix (aa: Thr285-Met292) to the central β sheet. It is worth mentioning that residue Thr285 is a catalytic residue for all phosphoenthanolamine transferases33,34,42. The formation of disulfide bond Cys281-Cys291 might restrain helical flexibility to accelerate the catalysis reaction. The third disulfide bridge Cys356-Cys364 is only shared between MCR-1C and LptA and it seems to arrest the conformational freedom of the loop (aa: Lys348–365) (Fig. 1b) and facilitate substrate entry. In contrast, there is no such a loop in this region of EptC (Fig. 1b), which may allow the entry of many different substrates. This is consistent with the multiple reactions catalyzed by EptC34.

Table 1. X-ray data collection and refinement statistics.

Parameters Data 1 Data 2
Data collection
Space group P212121 P212121
Cell dimensions
a, b, c (Å) a = 47.29, b = 62.70, c = 104.82 a = 47.31, b = 62.70, c = 104.83
α, β, γ (°) α = β = γ = 90° α = β = γ = 90°
Wavelength (Å) 0.91 0.91
Resolution range (Å) 50-1.55 (1.61–1.55)* 50-1.45 (1.50–1.45)*
No. of all observed reflections 46229 55886
Unique reflections 46163 (4484) 54741 (4348)
Completeness (%) 100.0 (100.0) 100.0 (100.0)
Rmerge (%) 0.085 (0.733) 0.078 (0.809)
I/σ(I) 34.7 (4.8) 23.6 (2.6)
Redundancy 14.0 (14.1) 7.8 (7.9)
Wilson B factor 12.69 13.45
Refinement
Resolution range (Å)   50–1.45
No. of reflections used   54740 (4348)
Reflections used in Rfree   2715 (228)
Rwork   0.1527 (0.223)
Rfree   0.1767 (0.240)
No. of nonhydrogen atoms   3080
Macromolecules   2573
Zn/Glycerol   3/2
Water   492
Protein residues   323
RMSD (bonds)   0.009
RMSD (angles)   1.44
Ramachandran favored (%)   97.6
Ramachandran allowed (%)   2.1
Ramachandran outliers (%)   0.3
Average B-factor (Å2)   23.70
Protein   21.28
Zn ions   15.25
Water   36.27
Open in a new tab

*Values in parentheses are for highest resolution shell.

Putative active site of MCR-1C

To study the putative active site, we over-expressed MCR-1C in E. coli BL21(DE3) plysS and the metal ions bound to the protein were characterized by ICP-MS method. In regular LB medium, the protein can bind Fe, Zn, Mg and Mn ions but prefers Zn as compared to other metal ions (Table 2). In a 50 μM ZnCl2 supplemented LB medium, MCR-1C can bind up to four zinc ions (Table 2) where three of them can be located in the structure as determined by SHELXD43 based on the anomalous signal. The fourth zinc ion might bind the protein non-specifically due to which we cannot identify it in the structure. This is also revealed in the newly published cMCR-1 (5K4P)42 where 10 zinc ions were identified in the structure with most of them locate on the surface coordinating to waters with low occupancy.

Table 2. ICP-MS assay of the ions contents in MCR-1.

Ions type Zn Fe Mg Mn Cr Co Cu Se Mo Cd Pb
Control 0.06 ± 0.07 0.05 ± 0.06 0.12 ± 0.15 <0.01 <0.01 <0.01 <0.01 <0.01 0.18 ± 0.31 <0.01 <0.01
MCR-1C (regular) 1.06 ± 0.61 0.36 ± 0.57 0.14 ± 0.21 0.06 ± 0.11 <0.01 <0.01 <0.01 <0.01 0.01 ± 0.01 <0.01 0.01 ± 0.02
MCR-1C (Zn) 4.02 ± 0.96 0.01 ± 0.01 0.02 ± 0.03 <0.01 <0.01 <0.01 <0.01 <0.01 0.13 ± 0.22 <0.01 <0.01
Open in a new tab

Metal ion quantities are calculated for per molecule of MCR-1C, and using 50 mM Tris (pH 8.0) buffer as control. MCR-1C (regular) was expression in regular LB medium and MCR-1C (Zn) was expression in LB medium containing 50 μM ZnCl2.

In our study among the three identified zinc ions in MCR-1C, two of them were located at the active site (Fig. 1a) and the third one located near residue Cys291. Similar to LptA and EptC, the first zinc ion (Zn1) is highly conserved in active site contacts and is coordinated to residues Glu246, Thr285, Asp465 and His46633,34,44 (Fig. 2). Beside the conserved orientations of these coordination residues among MCR-1C, LptA and EptC, we found that unlike LptA, EptC and even cMCR-142, Thr285 (a putative nucleophilic attacking residue in catalysis) is un-phosphorylated. The phosphorylated Thr285 is considered a catalysis intermediate during phosphate transfer33,34,42,45 thus stating MCR-1C the first native structure without any bound substrate or reaction intermediate. In contrast, Thr285 in cMCR-1 is phosphorylated and the coordination of Zn1 is very similar to that of LptA.

Figure 2. Active site conformations of MCR-1C, LptA and EptC.

Figure 2

Open in a new tab

Active site residues coordinated to metal ions were labeled and shown as ball-and-stick models. Metal ions were shown as balls and coordination bonds were shown as yellow dash lines. (a) Active site of MCR-1. Anomalous electron density map was shown for Zinc ions in green mesh at 20σ. Two water molecules involved in Zinc coordination were shown as red balls (W1 and W2). Residue E300 from a neighboring molecule also involved in coordination to Zn2 was shown with yellow carbons. Both Zinc ions were hexa-coordinated to protein residues and water molecules. (b) Active site of LptA (PDB code 4KAY). The coordination numbers for Zn1 and Zn2 were five and four, respectively. The phosphate group on phospho-Thr participated in Zinc coordination. (c) Active site of EptC. Only one Zinc ion was identified in EptC. The coordination number is five and phosphate group on phospho-Thr also participated in coordination. (d) Superposition of the active sites of MCR-1, LptA and EptC. All residues were well superimposed except one histidine residue (His358 in EptC) that involved in the coordination to Zn2 in MCR-1 and LptA.

Like the Zinc-soaked LptA (PDB: 4KAY), the second Zinc ion (Zn2) coordinates to two conserved histidine residues (His395 and His478 in MCR-1C) among some phospho-form transferases. However, the MCR-1C crystals uptake Zn ions from the medium for cell culture rather than soaking, suggesting a natural co-factor which is strong enough not to be washed off during protein purification. Due to un-phosphorylated nature, except the two histidine residues, Zn2 ion coordinates to water molecules and carboxylate moiety of Glu300 from a neighboring MCR-1C (Fig. 2a). The Glu300 interaction might not be observed in solution since MCR-1C is a monomer as determined by multi-angle light scattering method (Fig. S1). Moreover, this coordination could be fulfilled by the incoming substrate and possibly be a part of the catalytic mechanism. Crystals of the newly released cMCR-1 were obtained in a solution containing 0.2 M zinc acetate and Zn2 in this structure coordinates to the phosphate group and only one histidine residue His395, but not His47833,42, which is quite different from both LptA and our MCR-1C structure and needs further validation.

Discussion

The newly identified mcr-1 is a mobile colistin resistant gene and has been shown to rapidly spread among various bacterial strains through horizontal transfer and assisted its host in colistin resistance14. Since the broad-spectrum β-lactam antibiotics resistant gene, such as blaNDM-1, has spread all over the world, colistin is regarded as an important resort antibiotic against these superbugs12. Several studies have reported the presence of blaNDM-9 and mcr-1 in chicken meat samples27 including carbapenem and colistin double resistant E. coli strains19,29,30. Furthermore, mcr-1-harbouring plasmids have been reported in multi-drug resistant E. coli46,47, arising more threat to our healthcare system1.

Based on the published reports, it is imperative to study the molecular features and catalysis mechanism of MCR-1. This is the first study that reports the high-resolution crystal structure of the C-terminal catalytical domain of MCR-1 in native state. The overall structure of MCR-1C closely resembles the other two phosphoethanolamine transferases LptA and EptC. The intriguing difference among them is found to be at the loop (aa: Lys348–365) adjacent to the active site and might regulate substrate entry and specificity (Fig. 1b). Interestingly, the absence of this loop in EptC is anticipated to allow entry of different substrates (Fig. 1b). Our notion is supported by the fact that EptC retains the ability of catalyzing multiple reactions34.

At the putative active site, the presence of several conserved residues in phosphorylated transferases indicates that MCR-1C might also be a phosphoethanolamine transferase which needs to be confirmed by further biochemical and functional studies. The phosphorylated nature of active site residue Thr285 is considered an intermediate form in phospho-transfer reaction33,34,42,45, therefore we believe the unphosphorylated active site of MCR-1C to be in a native state before substrate binding.

The high resolution structure of MCR-1C sets up the primary basis for further study of substrate binding and catalysis mechanism. Future studies are required to search and validate MCR-1 inhibitors and block its enzymatic activities. The crystallographic and biophysical studies reported here lay the groundwork for developing new therapeutic strategies and chemicals against colistin resistant superbugs.

Materials and Methods

Protein expression and purification

Gene fragments of mcr-1 (corresponding to amino acid residue range of 219–541 and 181–541) were synthesized and inserted into plasmid pRHSUL2 (modified in our lab by insetting a His-SUMO tag at the 5′ open reading frame to pRSET A48). The plasmid was transferred into E. coli BL21(DE3) plysS cells and cultured at 37 °C. Protein expression was induced at cell density of OD600 = 0.6~0.8 with 0.5 mM IPTG and 50 μM ZnCl2 at 16 °C for 16~18 hrs. The cell pellets were harvested by centrifugation and lysed by sonication in lysis solution (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 0.5% (v/v) TritonX-100). The cell debris was removed by centrifugation and the cleared supernatant was loaded onto a HisTrap HP column (GE Healthcare) mounted on an AKTA pure (GE Healthcare). The column was washed with lysis buffer supplemented with 20 mM and 40 mM imidazole, and the protein was eluted with lysis buffer supplemented with 200 mM imidazole. The His-SUMO tag was cleaved by adding SUMO protease to the eluted protein fraction during dialysis to lower the concentration of imidazole. And then the protein was re-loaded to HisTrap column and the flow-through fraction was collected. The protein was further purified by anion exchange column HiTrap Q HP (GE Healthcare) at pH 8 with a sodium chloride gradient from 0 to 0.5 M. The purified protein was concentrated to 150 mg/ml (measured at OD280 with an extinction coefficient of 37735) in 20 mM Tris-HCl pH 8.0 for crystallization trials.

Crystallization, data collection and structure determination

Crystals of MCR-1 were obtained by the hanging drop vapor diffusion method at 20 °C by mixing 1 μl of purified protein and 1 μl of reservoir solution of 100 mM Tris-HCl pH 8.0 and 20% (v/v) PEG 4000. Columnar crystals appeared in a week. Fresh, single and large crystals of MCR-1 were soaked in 100 mM Tris-HCl pH 8.0, 20% (v/v) PEG 4000 and 16% (v/v) glycerol. The crystals were harvested with a nylon loop and immediately cooled in liquid nitrogen. Excitation scan was performed at beamline BL17U1 at Shanghai Synchrotron Radiation Facility (SSRF) at the Zinc absorption edge to confirm the identity of bound metal ions. The diffraction data were collected and processed using HKL200049. Solvent content and molecule number of MCR-1 per asymmetric unit were calculated using Matthews50.

The structure was solved using the SAS protocol of Auto-Rickshaw: the EMBL-Hamburg automated crystal structure determination platform51. The input diffraction data were prepared and converted for use in Auto-Rickshaw using programs of the CCP4 suite52. FA values were calculated using the program SHELXC53. Based on an initial analysis of the data, the maximum resolution for substructure determination and initial phase calculation was set to 1.7 Å. All of the 3 heavy atoms requested were found using the program SHELXD43. The correct hand for the substructure was determined using the programs ABS54 and SHELXE55. Initial phases were calculated after density modification using the program SHELXE. 95.36% of the model was built using the program ARP/wARP56,57. The model was refined with PHENIX58 and Refmac59 in CCP4 suite and cycled with rebuilding in COOT60. Solvents were added automatically in Coot and then manually inspected and modified. The final model was analyzed with MolProbity61, showing that 323 over 331 residues were in the favored region of Ramachandran plot and only one residue in outlier region (Ser330). The electron density map at residue S330 was very clear and there should be no doubt about its conformation. Data collection and model refinement statistics were summarized in Table 1. The coordinates and structure factors were deposited in PDB with entry code 5GRR. Structural figures were drawn with PyMOL62.

Metal ion identification

Metal ions bound by MCR-1 were identified through ICP-MS assays using Orbitrap Fusion Tribrid mass spectrometer (MS, Thermo Scientific) with the LCQ Fleet MS detector (Thermo Scientific) in the core facility of our university. Two different samples of MCR-1 were assayed and the contents of bound metal ions were compared, i.e. MCR-1 expressed in regular LB, MCR-1 expressed in LB supplemented with 50 μM ZnCl2. Three independent assays were performed for each sample and Table 2 listed the ion contents for each sample.

Additional Information

How to cite this article: Ma, G. et al. High resolution crystal structure of the catalytic domain of MCR-1. Sci. Rep. 6, 39540; doi: 10.1038/srep39540 (2016).

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Material

Supplementary Information
srep39540-s1.pdf (214.3KB, pdf)

Acknowledgments

This work was supported by grants from National Natural Science Foundation of China (project 31670753), Shenzhen government (ZDSYS20140509142721429) and SUSTC (FRG-SUSTC1501A-24) to H.Z. The X-ray diffraction data were collected at beamline BL17U1 at Shanghai Synchrotron Radiation Facility.

Footnotes

Author Contributions G.M., Y.Z. and Z.Y. conducted protein expression, purification and crystallographic experiments. G.M., Y.Z., A.A. and H.Z. analyzed data and wrote the manuscript. All authors reviewed the manuscript.

References

  1. Boucher H. W. et al. Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America. Clinical Infectious Diseases 48, 1–12, doi: 10.1086/595011 (2009). [DOI] [PubMed] [Google Scholar]
  2. Bonomo R. A. & Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 43 Suppl 2, S49–56, doi: 10.1086/504477 (2006). [DOI] [PubMed] [Google Scholar]
  3. Rahal J. J. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species. Clinical Infectious Diseases 43, S95–S99, doi: 10.1086/504486 (2006). [DOI] [PubMed] [Google Scholar]
  4. Livermore D. M. Has the era of untreatable infections arrived? J Antimicrob Chemoth 64, 29–36, doi: 10.1093/jac/dkp255 (2009). [DOI] [PubMed] [Google Scholar]
  5. Moellering R. C. NDM-1 - A Cause for Worldwide Concern. New Engl J Med 363, 2377–2379, doi: 10.1056/NEJMp1011715 (2010). [DOI] [PubMed] [Google Scholar]
  6. Yigit H. et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Ch 45, 1151–1161 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Yong D. et al. Characterization of a New Metallo-beta-Lactamase Gene, bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India. Antimicrob Agents Ch 53, 5046–5054, doi: 10.1128/Aac.00774-09 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Baiden F., Owusu-Agyei S., Webster J. & Chandramohan D. The need for new antibiotics. Lancet 375, 637–638 (2010). [DOI] [PubMed] [Google Scholar]
  9. Struelens M. J. et al. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Eurosurveillance 15, 9–16 (2010). [DOI] [PubMed] [Google Scholar]
  10. Kumarasamy K. K. et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10, 597–602, doi: 10.1016/S1473-3099(10)70143-2 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Munoz-Price L. S. et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13, 785–796, doi: 10.1016/S1473-3099(13)70190-7 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Paterson D. L. & Harris P. N. A. Colistin resistance: a major breach in our last line of defence. Lancet Infect Dis 16, 132–133, doi: 10.1016/S1473-3099(15)00463-6 (2016). [DOI] [PubMed] [Google Scholar]
  13. Doyle M. P., Loneragan G. H., Scott H. M. & Singer R. S. Antimicrobial Resistance: Challenges and Perspectives. Comprehensive Reviews in Food Science and Food Safety 12, 234–248, doi: 10.1111/1541-4337.12008 (2013). [DOI] [Google Scholar]
  14. Liu Y. Y. et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16, 161–168, doi: 10.1016/S1473-3099(15)00424-7 (2016). [DOI] [PubMed] [Google Scholar]
  15. Hasman H. et al. Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill 20, doi: 10.2807/1560-7917.ES.2015.20.49.30085 (2015). [DOI] [PubMed] [Google Scholar]
  16. Falgenhauer L. et al. Colistin resistance gene mcr-1 in extended-spectrum beta-lactamase-producing and carbapenemase-producing Gram-negative bacteria in Germany. Lancet Infect Dis, doi: 10.1016/S1473-3099(16)00009-8 (2016). [DOI] [PubMed] [Google Scholar]
  17. Perrin-Guyomard A. et al. Prevalence of mcr-1 in commensal Escherichia coli from French livestock, 2007 to 2014. Euro Surveill 21, doi: 10.2807/1560-7917.ES.2016.21.6.30135 (2016). [DOI] [PubMed] [Google Scholar]
  18. Kluytmans-van den Bergh M. F. et al. Presence of mcr-1-positive Enterobacteriaceae in retail chicken meat but not in humans in the Netherlands since 2009. Eurosurveillance 21, 12–18, doi: 10.2807/1560-7917.Es.2016.21.9.30149 (2016). [DOI] [PubMed] [Google Scholar]
  19. Zurfuh K. et al. Occurrence of the plasmid-borne mcr-1 colistin resistance gene in ESBL-producing Enterobacteriacae in river water and imported vegetable samples in Switzerland. Antimicrob Agents Chemother, doi: 10.1128/AAC.00066-16 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. McGann P. et al. Escherichia coli Harboring mcr-1 and blaCTX-M on a Novel IncF Plasmid: First report of mcr-1 in the USA. Antimicrob Agents Chemother, doi: 10.1128/AAC.01103-16 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Malhotra-Kumar S. et al. Colistin resistance gene mcr-1 harboured on a multidrug resistant plasmid. Lancet Infect Dis, doi: 10.1016/S1473-3099(16)00012-8 (2016). [DOI] [PubMed] [Google Scholar]
  22. Cannatelli A. et al. First Detection of the mcr-1 Colistin Resistance Gene in Escherichia coli in Italy. Antimicrob Agents Chemother 60, 3257–3258, doi: 10.1128/AAC.00246-16 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Malhotra-Kumar S. et al. Colistin-resistant Escherichia coli harbouring mcr-1 isolated from food animals in Hanoi, Vietnam. Lancet Infect Dis, doi: 10.1016/S1473-3099(16)00014-1 (2016). [DOI] [PubMed] [Google Scholar]
  24. Kempf I. et al. What do we know about resistance to colistin in Enterobacteriaceae in avian and pig production in Europe? Int J Antimicrob Ag 42, 379–383 (2013). [DOI] [PubMed] [Google Scholar]
  25. Gunn J. S. The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more. Trends in microbiology 16, 284–290 (2008). [DOI] [PubMed] [Google Scholar]
  26. Cannatelli A. et al. In Vivo Emergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoP mgrB Regulator. Antimicrob Agents Ch 57, 5521–5526 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Yao X., Doi Y., Zeng L., Lv L. & Liu J. H. Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1. Lancet Infect Dis, doi: 10.1016/S1473-3099(16)00057-8 (2016). [DOI] [PubMed] [Google Scholar]
  28. Haenni M. et al. Co-occurrence of extended spectrum beta lactamase and MCR-1 encoding genes on plasmids. Lancet Infect Dis, doi: 10.1016/S1473-3099(16)00007-4 (2016). [DOI] [PubMed] [Google Scholar]
  29. Yang Y. Q. et al. Co-occurrence of mcr-1 and ESBL on a single plasmid in Salmonella enterica. The Journal of antimicrobial chemotherapy, doi: 10.1093/jac/dkw243 (2016). [DOI] [PubMed] [Google Scholar]
  30. Du H., Chen L., Tang Y. W. & Kreiswirth B. N. Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae. Lancet Infect Dis, doi: 10.1016/S1473-3099(16)00056-6 (2016). [DOI] [PubMed] [Google Scholar]
  31. Di Pilato V. et al. MCR-1.2: a new MCR variant encoded by a transferable plasmid from a colistin-resistant KPC carbapenemase-producing Klebsiella pneumoniae of sequence type 512. Antimicrob Agents Chemother, doi: 10.1128/AAC.01075-16 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Cox A. D. et al. Phosphorylation of the lipid a region of meningococcal lipopolysaccharide: Identification of a family of transferases that add phosphoethanolamine to lipopolysaccharide. Journal of bacteriology 185, 3270–3277, doi: 10.1128/Jb.185.3270.3277.2003 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wanty C. et al. The Structure of the Neisserial Lipooligosaccharide Phosphoethanolamine Transferase A (LptA) Required for Resistance to Polymyxin. Journal of molecular biology 425, 3389–3402, doi: 10.1016/j.jmb.2013.06.029 (2013). [DOI] [PubMed] [Google Scholar]
  34. Fage C. D., Brown D. B., Boll J. M., Keatinge-Clay A. T. & Trent M. S. Crystallographic study of the phosphoethanolamine transferase EptC required for polymyxin resistance and motility in Campylobacter jejuni. Acta Crystallogr D 70, 2730–2739, doi: 10.1107/S1399004714017623 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Cullen T. W. & Trent M. S. A link between the assembly of flagella and lipooligosaccharide of the Gram-negative bacterium Campylobacter jejuni. Proceedings of the National Academy of Sciences of the United States of America 107, 5160–5165, doi: 10.1073/pnas.0913451107 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Cullen T. W., Madsen J. A., Ivanov P. L., Brodbelt J. S. & Trent M. S. Characterization of Unique Modification of Flagellar Rod Protein FlgG by Campylobacter jejuni Lipid A Phosphoethanolamine Transferase, Linking Bacterial Locomotion and Antimicrobial Peptide Resistance. Journal of Biological Chemistry 287, 3326–3336 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Cullen T. W. et al. EptC of Campylobacter jejuni Mediates Phenotypes Involved in Host Interactions and Virulence. Infection and immunity 81, 430–440, doi: 10.1128/Iai.01046-12 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Scott N. E. et al. Modification of the Campylobacter jejuni N-Linked Glycan by EptC Protein-mediated Addition of Phosphoethanolamine. Journal of Biological Chemistry 287, 29384–29396, doi: 10.1074/jbc.M112.380212 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Holm L. & Rosenstrom P. Dali server: conservation mapping in 3D. Nucleic acids research 38, W545–W549, doi: 10.1093/nar/gkq366 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Van Loo B., Schober M., Valkov E., Heberlein M., Faber K., Hyvonen M. & Hollfelder F. Structural and Mechanistic Analysis of the Choline Sulfatase from Sinorhizobium Melliloti: A Class I Sulfatase Specific for an Alkyl Sulfate Ester. (To Be Published). [DOI] [PMC free article] [PubMed]
  41. van Loo B. et al. An efficient, multiply promiscuous hydrolase in the alkaline phosphatase superfamily. Proceedings of the National Academy of Sciences of the United States of America 107, 2740–2745 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Stojanoski V. et al. Structure of the catalytic domain of the colistin resistance enzyme MCR-1. BMC Biol 14, 81, doi: 10.1186/s12915-016-0303-0 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Schneider T. R. & Sheldrick G. M. Substructure solution with SHELXD. Acta crystallographica. Section D, Biological crystallography 58, 1772–1779 (2002). [DOI] [PubMed] [Google Scholar]
  44. Jonas S., van Loo B., Hyvonen M. & Hollfelder F. A New Member of the Alkaline Phosphatase Superfamily with a Formylglycine Nucleophile: Structural and Kinetic Characterisation of a Phosphonate Monoester Hydrolase/Phosphodiesterase from Rhizobium leguminosarum. Journal of molecular biology 384, 120–136, doi: 10.1016/j.jmb.2008.08.072 (2008). [DOI] [PubMed] [Google Scholar]
  45. Schirner K., Marles-Wright J., Lewis R. J. & Errington J. Distinct and essential morphogenic functions for wall- and lipo-teichoic acids in Bacillus subtilis. The EMBO journal 28, 830–842, doi: 10.1038/emboj.2009.25 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Gao R., Wang Q., Li P., Li Z. & Feng Y. Genome sequence and characteristics of plasmid pWH12, a variant of the mcr-1-harbouring plasmid pHNSHP45, from the multi-drug resistant E. coli. Virulence 0, doi: 10.1080/21505594.2016.1193279 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Gao R., Li Y., Lin J., Tan C. & Feng Y. Unexpected complexity of multidrug resistance in the mcr-1-harbouring Escherichia coli. Science China. Life sciences, doi: 10.1007/s11427-016-5070-1 (2016). [DOI] [PubMed] [Google Scholar]
  48. Takao M. et al. A 127 Kda Component of a Uv-Damaged DNA-Binding Complex, Which Is Defective in Some Xeroderma-Pigmentosum Group-E Patients, Is Homologous to a Slime-Mold Protein. Nucleic acids research 21, 4111–4118, doi: 10.1093/nar/21.17.4111 (1993). [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Otwinowski Z. & Minor W. Processing of X-ray diffraction data collected in oscillation mode. Macromolecular Crystallography, Pt A 276, 307–326 (1997). [DOI] [PubMed] [Google Scholar]
  50. Matthews B. W. Solvent Content of Protein Crystals. Journal of molecular biology 33, 491–&, doi: 10.1016/0022-2836(68)90205-2 (1968). [DOI] [PubMed] [Google Scholar]
  51. Panjikar S., Parthasarathy V., Lamzin V. S., Weiss M. S. & Tucker P. A. Auto-Rickshaw: an automated crystal structure determination platform as an efficient tool for the validation of an X-ray diffraction experiment. Acta Crystallogr D 61, 449–457, doi: 10.1107/S0907444905001307 (2005). [DOI] [PubMed] [Google Scholar]
  52. Collaborative. The CCP4 suite: programs for protein crystallography. Acta Crystallographica Section D 50, 760–763, doi: 10.1107/S0907444994003112 (1994). [DOI] [PubMed] [Google Scholar]
  53. Sheldrick G. Macromolecular applications of SHELX. International Tables for Crystallography (Rossmann M. G. & Arnold E. eds), vol. F, 734–738 (2001). [Google Scholar]
  54. Hao Q. ABS: a program to determine absolute configuration and evaluate anomalous scatterer substructure. J Appl Crystallogr 37, 498–499 (2004). [Google Scholar]
  55. Sheldrick G. M. Macromolecular phasing with SHELXE. Zeitschrift für Kristallographie-Crystalline Materials 217, 644–650 (2002). [Google Scholar]
  56. Perrakis A., Morris R. & Lamzin V. S. Automated protein model building combined with iterative structure refinement. Nature structural & molecular biology 6, 458–463 (1999). [DOI] [PubMed] [Google Scholar]
  57. Morris R. J. et al. Breaking good resolutions with ARP/wARP. J Synchrotron Radiat 11, 56–59 (2004). [DOI] [PubMed] [Google Scholar]
  58. Adams P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D 58, 1948–1954 (2002). [DOI] [PubMed] [Google Scholar]
  59. Murshudov G. N., Vagin A. A. & Dodson E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D 53, 240–255, doi: 10.1107/S0907444996012255 (1997). [DOI] [PubMed] [Google Scholar]
  60. Emsley P. & Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D 60, 2126–2132 (2004). [DOI] [PubMed] [Google Scholar]
  61. Chen V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D 66, 12–21, doi: 10.1107/S0907444909042073 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. DeLano W. L. The PyMOL molecular graphics system (2002). [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Information
srep39540-s1.pdf (214.3KB, pdf)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES